University of Minnesota officials report they’ve received a $51 million federal grant for medical research to “increase community involvement in the research process and the efficiency and speed at which the results of clinical trials translate into new treatments, cures and improved health outcomes.”
This Clinical and Translational Science Award from the National Institutes of Health is the largest single-institution grant in the history of the University.
“Successfully competing for the CTSA is a major victory for the University of Minnesota,” said President Robert H. Bruininks. “This is just the latest example of the ways in which the extraordinary knowledge and productivity of our talented faculty and staff garner new resources, discover new knowledge, and develop real solutions to health concerns in Minnesota, across the nation, and around the world. I am proud of the hard work and dedication our people have exhibited to bring this transformative award to fruition.”
Dr. Aaron Friedman, vice president for Health Sciences and dean of the Medical School, said the grant will also tie together research taking place across focus areas known as the University’s Corridors of Discovery: cancer, cardiology, diabetes, infectious diseases and brain sciences.
“With this distinguished grant award, the NIH recognizes the strength of our University’s clinical research enterprise and our extraordinary capacity to translate scientific breakthroughs into improved health and well-being,” said Friedman.